Xenon Pharmaceuticals (XENE)
Develops azetukalner and ion-channel medicines for epilepsy, depression, and pain.
$39.18
After hours+0.10 (+0.27%)
At close$39.08(+0.22%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 41 days
EPS estimate
−$1.17
Revenue estimate
$1.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.84−$0.83−$1.07−$1.15−$1.31−$1.17−$1.11Pending
Estimate−$0.89−$0.94−$1.03−$1.16−$1.20−$1.17−$1.14−$1.17
Surprise+5.6%+11.7%−3.9%+0.9%−9.2%0.0%+2.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported—$7.5M—————Pending
Estimate$312.5K$1.9M——−$178.6K$1.4M$1.7M$1.3M
Surprise—+293.4%——————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.21 | — | — |
| Sep 2027 | −$1.22 | — | — |
| Jun 2027 | −$1.24 | — | — |
| Mar 2027 | −$1.23 | — | — |
| Dec 2026 | −$1.16 | — | — |
| Nov 2026 | −$1.17 | — | — |
| Aug 2026 | −$1.14 | −$1.11 | +2.6% |
| May 2026 | −$1.17 | −$1.17 | 0.0% |
| Feb 2026 | −$1.20 | −$1.31 | −9.2% |
| Nov 2025 | −$1.16 | −$1.15 | +0.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.21 | — | — | $10.2M | — | — | — |
| Sep 2027 | −$1.22 | — | — | $8.8M | — | — | — |
| Jun 2027 | −$1.24 | — | — | $50.0K | — | — | — |
| Mar 2027 | −$1.23 | — | — | $0 | — | — | — |
| Dec 2026 | −$1.16 | — | — | $1.4M | — | — | — |
| Nov 2, 2026 | −$1.17 | — | — | $1.3M | — | — | — |
| Aug 6, 2026 | −$1.14 | −$1.11 | +2.6% | $1.7M | — | — | −1.8% |
| May 7, 2026 | −$1.17 | −$1.17 | 0.0% | $1.4M | — | — | +0.8% |
| Feb 26, 2026 | −$1.20 | −$1.31 | −9.2% | −$178.6K | — | — | −3.8% |
| Nov 3, 2025 | −$1.16 | −$1.15 | +0.9% | — | — | — | −4.9% |
| Aug 11, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 1, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 21, 2020 | |||||||
| Mar 9, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 6, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 8, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 10, 2015 |